Home›Stock Screener›Nephro Care›Financial Statements

Nephro Care Financial Statements

2 Years of Data
2026 - 2025

Nephro Care financial statements. In FY2026, Nephro Care (NEPHROCARE) reported revenue ₹33 Cr, net profit ₹3 Cr and EPS ₹1.67, with a net profit margin of 9.1% and ROE of 5.3%. Full financial statements from FY2025 to FY2026 (2 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore NEPHROCARE true value to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 9.09% 2026 data
EBITDA Margin 15.15% 2026 data
Operating Margin 15.00% 2026 data
Return on Assets 4.11% 2026 data
Return on Equity 5.26% 2026 data

Balance Sheet Ratios

Equity Ratio 78.08% 2026 data
Asset Turnover 0.45 2026 data

NEPHROCARE Revenue, Net Profit & EBITDA — Year-on-Year Growth

NEPHROCARE YoY (Sept 2025 vs Sept 2026) — revenue +43.5%, EBITDA +25.0%, expenses +61.1%. See NEPHROCARE book value comparison to compare market price against book value per share.

Revenue Growth
+43.5%
Year-over-Year
EBITDA Growth
+25.0%
Year-over-Year
Expense Growth
+61.1%
Year-over-Year

NEPHROCARE Income Statement — Revenue, EBITDA & Net Profit

Nephro Care revenue ₹33 Cr, EBITDA ₹5 Cr, net profit ₹3 Cr, EPS ₹1.67 (2026) — net profit margin 9.1%. For live price, earnings ratios and company overview, see NEPHROCARE share price screener.

Periods ₹ Crores
Particulars Sept 2026 Mar 2026 Jun 2026 Sept 2025 Jun 2025 Dec 2025
Revenue 33 28 29 23 17 23
Expenses 29 25 26 18 17 21
EBITDA 5 3 4 4 1 2
Operating Profit Margin % 15.00% 8.00% 12.00% 17.00% 3.00% 8.00%
Depreciation 1 2 1 1 1 1
Interest 0 0 0 0 0 0
Profit Before Tax 4 1 3 3 -1 1
Tax 1 0 1 1 0 0
Net Profit 3 1 2 3 -1 0
Earnings Per Share (₹) 1.67 0.61 0.98 1.57 -0.39 0.26

NEPHROCARE Balance Sheet — Assets, Liabilities & Shareholders' Equity

NEPHROCARE total assets ₹73 Cr, total equity ₹57 Cr, total liabilities ₹ Cr (2026) — ROE 5.3%.

Years Annual Data ₹ Crores
Particulars 2026
ASSETS
Total Assets 73
Current Assets
Fixed Assets 34
Capital Work in Progress 1
Investments 10
Other Assets 28
LIABILITIES
Total Liabilities
Current Liabilities 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 57
Share Capital 17
Reserves & Surplus 40

NEPHROCARE Cash Flow Statement — Operating, Investing & Financing

Nephro Care operating cash flow ₹2 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹2 Cr (2026).

Periods ₹ Crores
Particulars March 2026
Operating Activities 2
Investing Activities 0
Financing Activities 0
Net Cash Flow 2